Articles mentioning Orexigen Therapeutics, Inc. (OREX)

Results 1 - 10 of 109 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for OREX

Investing | January 11, 2012

Has Arena Pharmaceuticals Become the Perfect Stock?

Finding companies that have all the right stuff can produce winners.

High-Growth Investing | January 09, 2012

Don't Believe This Company's Warning

VIVUS' news is great news.

High-Growth Investing | January 04, 2012

This Biotech's Obese To-Do List Is Done

Arena resubmits lorcaserin for FDA approval.

Investing | December 30, 2011

Working Through the Obese To-Do List in 2011

Arena ends the year on an upswing.

High-Growth Investing | December 22, 2011

VIVUS' Obese Pink Elephant

Qnexa data can't be ignored.

High-Growth Investing | November 12, 2011

These 2 Biotechs Got Crushed

Highlighting the day's health-care stories critical to investors.

High-Growth Investing | November 11, 2011

Aeterna Zentaris Surprises Again

A quarterly profit shocks analysts and me alike.

Investing | October 07, 2011

3 Stocks Shaking the Market

These stocks have been looking up over the past month.

High-Growth Investing | September 26, 2011

Closer to Approval, Now Can MELA Find Customers?

The restrictions might be too much.

High-Growth Investing | September 21, 2011

Obesity-Drug Makers Stop Getting Bullied

Don't count on approvals; they're still a long shot.

Results 1 - 10 of 109 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for OREX


Advertisement